Evidence map›Paper›PMID 30372040›Full record

ArticleBioconjugate chemistry2018

Chemoenzymatic Synthesis of Galectin Binding Glycopolymers.

Jessica H Ennist, Henry R Termuehlen, Samuel P Bernhard, Mackenzie S Fricke, Mary J Cloninger

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Nanoparticles To Study Lectins inBiomacromolecules · 2021
    Article
  6. Synthesis of Galectin Inhibitors by Regioselective 3'-Molecules (Basel, Switzerland) · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jessica H EnnistDepartment of Chemistry and Biochemistry , Montana State University , Bozeman , Montana 59717 , United States.
Henry R TermuehlenDepartment of Chemistry and Biochemistry , Montana State University , Bozeman , Montana 59717 , United States.
Samuel P BernhardDepartment of Chemistry and Biochemistry , Montana State University , Bozeman , Montana 59717 , United States.
Mackenzie S FrickeDepartment of Chemistry and Biochemistry , Montana State University , Bozeman , Montana 59717 , United States.
Mary J CloningerDepartment of Chemistry and Biochemistry , Montana State University , Bozeman , Montana 59717 , United States.ORCID 0000-0002-7551-1003
Montana State University · US

Funding

Using Dendrimers to Design Multivalent Therapeutic AgentsR01GM062444 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI CLONINGER, MARY J · 2001 to 2015
$3.5M
NIGMS NIH HHS R01 GM062444
6 · The paper itself

Abstract

Chemoenzymatic synthesis is an important strategy for the formation of glycopolymers. The use of a smaller number of traditional chemical steps and enzyme catalyzed reactions increases the yield of glycopolymer that can be produced by reducing the overall number of synthetic steps. In addition, chemoenzymatic routes are likely to be more accessible to those without a background in carbohydrate synthesis, making glycopolymers more available for studies across a broader range of scientists. Here, the enzymatic addition of galactose to N-acetylglucosamine functionalized glycodendrimers reduced the requisite number of synthetic steps for the full chemical synthesis of N-acetyl lactosamine (Lac NAc) functionalized dendrimers to four steps. Unpurified cell lysate was used in the enzyme catalyzed glycosylation, and product glycodendrimers were readily purified by dialysis after enzymatic degradation of all protein components of the lysate in the crude reaction mixture. Lac NAc functionalized dendrimers were used very effectively in homotypic cancer cellular aggregation assays and were found to either inhibit or enhance galectin-3 mediated cancer cellular aggregation, with differences in outcomes dependent on the generation of Lac NAc functionalized dendrimers that were used.

Indexed as

AcetylglucosamineAmino SugarsBinding SitesCarbohydratesCell Line, TumorEnzymesGalectinsGlycosylationHumansPolymersAcetylglucosamineAmino SugarsCarbohydratesEnzymesGalectinsN-acetyllactosaminePolymers

Identifiers

PMID30372040
PMCPMC9389845
OpenAlexW2899414590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.